🇺🇸 Benzathine penicillin G in United States

122 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 122

Most-reported reactions

1. Drug Hypersensitivity — 79 reports (64.75%)
2. No Adverse Event — 8 reports (6.56%)
3. Urticaria — 8 reports (6.56%)
4. Rash — 6 reports (4.92%)
5. Pruritus — 5 reports (4.1%)
6. Pyrexia — 5 reports (4.1%)
7. Dizziness — 3 reports (2.46%)
8. Drug Ineffective — 3 reports (2.46%)
9. Foetal Exposure During Pregnancy — 3 reports (2.46%)
10. Acute Generalised Exanthematous Pustulosis — 2 reports (1.64%)

Source database →

Frequently asked questions

Is Benzathine penicillin G approved in United States?

Benzathine penicillin G does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Benzathine penicillin G in United States?

International Maternal Pediatric Adolescent AIDS Clinical Trials Group is the originator. The local marketing authorisation holder may differ — check the official source linked above.